Today, the best-performing stocks in the U.S. pharmaceutical sector are those deeply involved in AI-driven drug development.


Perhaps it was catalyzed by Moderna's Science Day yesterday, where the CEO emphasized that AI can significantly shorten the new drug development cycle and greatly reduce trial-and-error costs, backed by data.
Bookmark these stocks below; the breakout may not require waiting five years.
View Original
post-image
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned